China SXT Pharmaceuticals (SXTC) Notes Payables (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Notes Payables of $355175.0 for Q1 2026, down 49.42% year-over-year from $702184.0 in Q1 2025, and down 63.62% quarter-over-quarter from $976367.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Notes Payables (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Notes Payables history runs 8 years deep, the most recent figure standing at $355175.0 for Q1 2026.
- In Q1 2026, Notes Payables fell 49.42% year-over-year to $355175.0; the TTM figure through Mar 2026 stood at $355175.0 (down 49.42% YoY), while the FY2026 annual figure was $355175.0, down 49.42% from the prior year.
- Notes Payables for Q1 2026 stood at $355175.0, down from $976367.0 in the prior quarter.
- The five-year high for Notes Payables was $976367.0 in Q3 2025, with the low at $5822.0 in Q3 2023.
- The 4-year median for Notes Payables is $493054.0 (2024), against an average of $486034.1.
- The sharpest annual moves came in 2024 and 2026: Notes Payables jumped 11960.87% in 2024, then tumbled 49.42% in 2026.
- China SXT Pharmaceuticals' Notes Payables stood at $5822.0 in 2023, then surged by 11960.87% to $702184.0 in 2024, then soared by 39.05% to $976367.0 in 2025, then plunged by 63.62% to $355175.0 in 2026.
- Business Quant data shows SXTC's Notes Payables at $355175.0 in Q1 2026, $976367.0 in Q3 2025, and $702184.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 355,175.00 |
| Sep 30, 2025 | 976,367.00 |
| Mar 31, 2025 | 702,184.00 |
| Sep 30, 2024 | 702,184.00 |
| Mar 31, 2024 | 493,054.00 |
| Sep 30, 2023 | 5,822.00 |
| Mar 31, 2023 | 167,453.00 |
| Sep 30, 2021 | 24,042.00 |
| Mar 31, 2021 | 37,122.00 |
| Sep 30, 2020 | 45,757.00 |
| Mar 31, 2020 | 43,902.00 |
| Sep 30, 2019 | 62,533.00 |
| Mar 31, 2019 | 233,336.00 |
| Sep 30, 2018 | 192,611.00 |
| Mar 31, 2018 | 385,121.00 |